Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer launches freezer pops for cough relief
The taste of liquid remedies or the sight of pills often send children burrowing beneath their covers and can be messy or difficult for children to take. Children’s
The taste of liquid remedies or the sight of pills often send children burrowing beneath their covers and can be messy or difficult for children to take. Children’s
The phase II clinical trial is a multi-center, open-label study to evaluate the efficacy, safety and tolerability of HGS-ETR1 (mapatumumab), an agonistic human monoclonal antibody to TRAIL receptor
Orathecin (rubitecan) is an orally active camptothecin that is being developed for the treatment of pancreatic cancer and gemcitabine is a chemotherapy drug sold under the brand name
This collaboration builds on the initial R&D conducted by Corixa and Apovia for the development of a therapeutic vaccine for the treatment of hepatitis B. Lorantis has acquired
MBX-2044 is designed to eliminate the dose-limiting side effects of the currently marketed sensitizers. Data from the phase I dose-escalating study showed that the drug was well-tolerated in
Countries covered by the agreement include Japan, South Korea, China, Taiwan and Singapore and the licensing agreement provides for, among other things, equity payments, milestone payments and double
Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed. SRL will distribute miRview mets,
Axxima’s assets were transferred to a newly formed holding company in which certain investors injected an additional net E8.7 million in cash. GPC Biotech will purchase the holding
Fortamet (metformin HCl), a treatment for type 2 diabetes, and Atroprev (lovastatin), a cholesterol-managing medicine, are both part of Andrx’ branded products division. First Horizon has agreed to
The basis for the agreed revisions to the prescribing labeling for Crestor, which strengthen points contained in the original labeling, include modifications to dosage instruction; recent clinical trial